Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

137.05
+2.431.81%
Post-market: 137.900.8500+0.62%19:54 EDT
Volume:67.35K
Turnover:9.26M
Market Cap:185.02M
PE:- -
High:141.50
Open:139.31
Low:135.96
Close:134.62
52wk High:150.00
52wk Low:74.34
Shares:1.35M
Float Shares:1.35M
Volume Ratio:1.27
T/O Rate:4.99%
Dividend:1.27
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly & Co. Stock Advances 4.9%, Outperforms Peers

Dow Jones
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Dow Jones
·
Aug 06

SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Eli Lilly Doesn't Want to be Seen as 'Just an Obesity Company'

Dow Jones
·
Aug 06

Eli Lilly is Leading the Pharmaceutical Segment, CEO Says

Dow Jones
·
Aug 06

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion

Benzinga Earnings
·
Aug 06

Top Midday Stories: SpaceX Shares Fall After Inaugural Results; AMD Drops Despite Strong Q2 EPS, Revenue

MT Newswires Live
·
Aug 05

Eli Lilly (LLY) Could Be 24% Below Fair Value As Revenue Outlook Rises

Simply Wall St.
·
Aug 05

LIVE Markets-Wall Street Looks up Beyond Earnings-Driven Selloffs

Reuters
·
Aug 05

Lilly Exec Says Foundayo Prescriptions Doubled in Late July from a Month Earlier

THOMSON REUTERS
·
Aug 05

Lilly Exec Says About 55% of Overall Zepbound Prescriptions are Self Pay

THOMSON REUTERS
·
Aug 05

Eli Lilly's Second-Quarter Results Beat Estimates, Company Raises Full-Year Revenue Guidance

Deep News
·
Aug 05

Eli Lilly Stock: the One Question in Otherwise Perfect Earnings and What it Means for Shares

Dow Jones
·
Aug 05

Lilly CFO Says Expects Global Rollout of Foundayo in All Major Markets in 2027

THOMSON REUTERS
·
Aug 05

Eli Lilly and Co Stock (LLY) Moved Up by 6.32% on Aug 5: A Full Analysis

TradingKey
·
Aug 05

Lilly Stock Jumps on Strong GLP-1 Sales

Dow Jones
·
Aug 05

Eli Lilly CFO Says Injectable Glp-1 Drugs Remain Key Growth Driver, Account for Three Out of Four New Patient Starts: Conf Call

THOMSON REUTERS
·
Aug 05

Eli Lilly Shares Surge Nearly 6% at Market Open

Deep News
·
Aug 05

Eli Lilly Lifts Annual Revenue Forecast After Blockbuster Drug Sales Surge Overseas

Deep News
·
Aug 05